The Dark Side of Open-Access Journals | GenomeWeb

A growing number of open-access journals of questionable reputation are offering to publish "seemingly anything" for a fee and are preying on researchers to lend them credibility, The New York Times reports today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Open-Access Costs

Make a Note

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.